Healthcare Value Capital’s Allergan plc AGN Stock Holding History

Healthcare Value Capital’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-30,000	Closed	-$4.39M	–	22
2019 Q1	$4.39M	Buy	30,000 +10,000	+50%	+$1.45M	16.92%	1
2018 Q4	$2.67M	Hold	20,000	–	–	10.39%	5
2018 Q3	$3.81M	Hold	20,000	–	–	9.21%	5
2018 Q2	$3.33M	Buy	+20,000	New	+$3.21M	9.45%	5
2017 Q3	–	Sell	-15,000	Closed	-$3.65M	–	20
2017 Q2	$3.65M	Hold	15,000	–	–	6.55%	8
2017 Q1	$3.58M	Hold	15,000	–	–	6.13%	8
2016 Q4	$3.15M	Buy	+15,000	New	+$3.11M	3.37%	11
2016 Q2	–	Sell	-10,000	Closed	-$2.68M	–	33
2016 Q1	$2.68M	Hold	10,000	–	–	3.94%	9
2015 Q4	$3.13M	Hold	10,000	–	–	5.17%	8
2015 Q3	$2.72M	Hold	10,000	–	–	3.88%	10
2015 Q2	$3.04M	Hold	10,000	–	–	3.19%	12
2015 Q1	$2.98M	Buy	+10,000	New	+$2.85M	3.24%	13
2014 Q4	–	Sell	-30,000	Closed	-$7.24M	–	37
2014 Q3	$7.24M	Buy	+30,000	New	+$6.71M	6.98%	4
2013 Q4	–	Sell	-12,524	Closed	-$1.8M	–	47
2013 Q3	$1.8M	Hold	12,524	–	–	1.58%	28
2013 Q2	$1.58M	Buy	+12,524	New	+$1.42M	1.15%	31

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Healthcare Value Capital's AGN Position: Q2 2019 in Review

Healthcare Value Capital sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 30,000 shares — an estimated $4.39M sold.

Healthcare Value Capital first reported a position in AGN in Q2 2013 and held it in 15 quarters. The position peaked at $7.24M in Q3 2014. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

Healthcare Value Capital reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
Healthcare Value Capital sold 30,000 Allergan plc shares in Q2 2019, an estimated $4.39M.
Healthcare Value Capital first reported a position in Allergan plc in Q2 2013 and held it in 15 quarters.
Healthcare Value Capital's Allergan plc position peaked at $7.24M in Q3 2014.
971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Healthcare Value Capital's 13F filing for Q2 2019, filed 14 Aug 2019.